Segmenting permeability, neovascularization, necrosis, collagen breakdown, or inflammation to characterize atherosclerotic plaque, coronary artery disease, or vasculopathy
US12106477B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2023 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Dec 19, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG06V2201/03
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.